aminolevulinic acid has been researched along with Leishmaniasis, Diffuse Cutaneous in 2 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Leishmaniasis, Diffuse Cutaneous: A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sohl, S | 1 |
Kauer, F | 1 |
Paasch, U | 1 |
Simon, JC | 1 |
Oster-Schmidt, C | 1 |
2 other studies available for aminolevulinic acid and Leishmaniasis, Diffuse Cutaneous
Article | Year |
---|---|
Photodynamic treatment of cutaneous leishmaniasis.
Topics: Aminolevulinic Acid; Humans; Leishmaniasis, Diffuse Cutaneous; Male; Middle Aged; Photochemotherapy; | 2007 |
[Comment on: "Photodynamic treatment of cutaneous leishmaniasis"].
Topics: Aminolevulinic Acid; Humans; Leishmaniasis, Diffuse Cutaneous; Male; Middle Aged; Photochemotherapy; | 2007 |